Market Overview:
The global peptide synthesis market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the peptide synthesis market can be attributed to the increasing demand for peptides from various applications such as commercial and academic research. The global peptide synthesis market is segmented on the basis of type, application, and region. On the basis of type, the global peptide synthesis market is segmented into CRO Peptides, CMO Peptides, and Generic API Peptides. The CRO Peptides segment is projected to grow at a higher CAGR during the forecast period owing to rising demand for custom-made peptides for drug discovery and development activities by pharmaceutical companies across the globe. On the basis of application,the global peptide synthesis market is divided into commercial applications and academic research applications. Commercial applications are further sub-segmented into therapeutic proteins & vaccines; diagnostics & biomarkers; agrochemicals; nutraceuticals & cosmeceuticals; industrial enzymes; food additives & supplements; other commercial applications Academic research Applications are further sub-segmented into structural biology/proteomics ; pharmacology/toxicology ; cell signaling ; immunology/inflammation ; other academic research applications .
Product Definition:
A peptide is a molecule consisting of two or more amino acids linked by peptide bonds. Peptides are synthesized by the sequential addition of amino acids to the carboxyl end of a preceding amino acid, known as the N-terminus. The process of creating peptides is called peptide synthesis.
CRO Peptides:
CRO peptides are short for Contract Research Organization peptides. They are amino-acid sequences that are specifically manufactured and supplied by CROs to the research institutes/clinics for use in various applications such as drug discovery, clinical trials, etc. The global market is expected to grow at a lucrative rate during the forecast period owing to increasing R&D activities coupled with growing demand from emerging economies of Asia Pacific and Latin America regions.
CMO Peptides:
CMO peptides are short for Cell Membrane Protein. They are naturally occurring peptides that occur in very small quantities within the cell membranes of all organisms. CMO peptide is a single amino acid long linear polypeptide comprising an amino terminal signal sequence and a carboxyl terminal propeptide.
Application Insights:
The academic research segment held the largest share of over 70.0% in 2017. The peptide synthesis techniques have numerous applications in various fields of biology and medicine, especially in the academic research sector. This is due to extensive R&D that goes into developing a new drug with improved efficacy and fewer side effects compared to other drugs.
Commercial application is expected to witness the fastest growth at a CAGR of XX% from 2018 to 2030 owing to increasing product utilization for producing medicines for treating life-threatening diseases such as cancer, diabetes & obesity, cardiovascular disorders, respiratory problems and gastrointestinal conditions among others which require highly specific drug formulations for effective treatment outcomes (1).
However, there are certain disadvantages associated with this technique including high cost as well as time complexity involved during peptide synthesis process which may affect its adoption rate among large-scale pharmaceutical companies preferring instead automated mass production techniques over handcrafted solutions (2).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of peptide developers and manufacturers. Moreover, increasing R&D spending by companies and rising adoption of advanced technologies are expected to drive growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period due to growing healthcare expenditure, improving healthcare infrastructure, rising awareness about new therapies for disease management, and availability of effective CMOs at affordable prices. In addition, increasing focus on drug discovery activities by local players is anticipated to propel demand in this region.
Growth Factors:
- Increasing demand for peptides in the pharmaceutical and biotechnology industries as therapeutics and research tools
- Growing popularity of peptide-based drugs over traditional small molecule drugs
- Rising number of collaborations between pharmaceutical companies and peptide synthesis service providers to develop novel therapeutics
- Proliferation of personalized medicine approaches that require customized peptides for individual patients
- Technological advancements in peptide synthesis methodology that improve yields, purity, and scale
Scope Of The Report
Report Attributes
Report Details
Report Title
Peptide Synthesis Market Research Report
By Type
CRO Peptides, CMO Peptides, Generic API Peptides
By Application
Commercial, Academic Research
By Companies
Bachem, PolyPeptide, USV Peptides, Thermofischer, GL Biochem, Hybio, Bio Basic, JPT, Genscript, Xinbang, ScinoPharm, 21st Century Bio, CPC Scientific, LifeTein, AnaSpec, New England Peptide, Biomatik, Proimmune
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Peptide Synthesis Market Report Segments:
The global Peptide Synthesis market is segmented on the basis of:
Types
CRO Peptides, CMO Peptides, Generic API Peptides
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Commercial, Academic Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bachem
- PolyPeptide
- USV Peptides
- Thermofischer
- GL Biochem
- Hybio
- Bio Basic
- JPT
- Genscript
- Xinbang
- ScinoPharm
- 21st Century Bio
- CPC Scientific
- LifeTein
- AnaSpec
- New England Peptide
- Biomatik
- Proimmune
Highlights of The Peptide Synthesis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CRO Peptides
- CMO Peptides
- Generic API Peptides
- By Application:
- Commercial
- Academic Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peptide Synthesis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peptide synthesis is the process of creating peptides from amino acids. Peptides are short chains of amino acids that can have a variety of functions in the body.
Some of the major companies in the peptide synthesis market are Bachem, PolyPeptide, USV Peptides, Thermofischer, GL Biochem, Hybio, Bio Basic, JPT, Genscript, Xinbang, ScinoPharm, 21st Century Bio, CPC Scientific, LifeTein, AnaSpec, New England Peptide, Biomatik, Proimmune.
The peptide synthesis market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peptide Synthesis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Peptide Synthesis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Peptide Synthesis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Peptide Synthesis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Peptide Synthesis Market Size & Forecast, 2020-2028
4.5.1 Peptide Synthesis Market Size and Y-o-Y Growth
4.5.2 Peptide Synthesis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 CRO Peptides
5.2.2 CMO Peptides
5.2.3 Generic API Peptides
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Commercial
6.2.2 Academic Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Peptide Synthesis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Peptide Synthesis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 CRO Peptides
9.6.2 CMO Peptides
9.6.3 Generic API Peptides
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Commercial
9.10.2 Academic Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 CRO Peptides
10.6.2 CMO Peptides
10.6.3 Generic API Peptides
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Commercial
10.10.2 Academic Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 CRO Peptides
11.6.2 CMO Peptides
11.6.3 Generic API Peptides
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Commercial
11.10.2 Academic Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 CRO Peptides
12.6.2 CMO Peptides
12.6.3 Generic API Peptides
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Commercial
12.10.2 Academic Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 CRO Peptides
13.6.2 CMO Peptides
13.6.3 Generic API Peptides
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Commercial
13.10.2 Academic Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Peptide Synthesis Market: Competitive Dashboard
14.2 Global Peptide Synthesis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bachem
14.3.2 PolyPeptide
14.3.3 USV Peptides
14.3.4 Thermofischer
14.3.5 GL Biochem
14.3.6 Hybio
14.3.7 Bio Basic
14.3.8 JPT
14.3.9 Genscript
14.3.10 Xinbang
14.3.11 ScinoPharm
14.3.12 21st Century Bio
14.3.13 CPC Scientific
14.3.14 LifeTein
14.3.15 AnaSpec
14.3.16 New England Peptide
14.3.17 Biomatik
14.3.18 Proimmune
